Regeneron Pharmaceuticals | REGN - Loan Capital

Regeneron Pharmaceuticals reported $2.7B in Loan Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Loan Capital Change
Alimera Sciences ALIM:US USD 22.49M 6.8M
Alnylam Pharmaceuticals ALNY:US USD 1.02B 967K
Amgen AMGN:US USD 37.35B 193M
Astellas Pharma 4503:JP JPY 148.74B 66.35B
AstraZeneca AZN:LN USD 23.69B 9M
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
Esperion Therapeutics ESPR:US USD 259.9M 412K
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
Intercept Pharmaceuticals ICPT:US USD 223.1M 248K
IONIS PHARMACEUT IONS:US USD 1.18B 66.78M
Kyowa Hakko Kirin 4151:JP JPY 17.55B 1.8B
Moderna Inc MRNA:US USD 912M 10M
Novartis NOVN:VX USD 21.78B 547M
Novartis NVS:US USD 21.78B 547M
Puma Biotechnology PBYI:US USD 98.31M 313K
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 21.39B 978M
Sarepta Therapeutics SRPT:US USD 1.54B 1.52M
Teva Pharmaceutical TEVA:IT USD 19.1B 606M
United Therapeutics UTHR:US USD 800M 0
Vertex Pharmaceuticals VRTX:US USD 471.6M 29.3M
YTE INCY:US USD 30.08M 393K